Filing Details
- Accession Number:
- 0001415889-23-002714
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-17 06:29:03
- Reporting Period:
- 2023-02-15
- Accepted Time:
- 2023-02-17 06:29:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1159036 | Halozyme Therapeutics Inc. | HALO | Biological Products, (No Disgnostic Substances) (2836) | 880488686 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1507174 | J. Michael Labarre | C/O Halozyme Therapeutics, Inc. 12390 El Camino Real San Diego CA 92130 | Svp, Chief Technical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-02-15 | 10,000 | $48.39 | 143,477 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-02-15 | 3,386 | $0.00 | 146,863 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-15 | 1,170 | $49.20 | 145,693 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2023-02-15 | 3,386 | $0.00 | 3,386 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,772 | No | 4 | M | Direct |
Footnotes
- This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The reported disposition of 1,170 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
- This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
Billionaire Hedge Funds
